EVolution Therapeutics is thrilled to announce its selection to join the first cohort of SPARK The Midlands, the inaugural UK branch of the globally recognised Stanford preclinical accelerator model. Collaborating with esteemed partners like Aston University and the West Midlands Health Tech Innovation Accelerator (WMHTIA), this programme aims to empower academics, healthcare professionals, and entrepreneurs in addressing pressing unmet clinical needs within healthcare.
SPARK The Midlands offers an array of resources, including specialised knowledge, technical expertise, and funding avenues, all geared towards facilitating the translation of innovative ideas into tangible healthcare solutions. Through participation in SPARK UK workshops led by industry leaders, EVolution Therapeutics will gain invaluable insights into various facets of therapeutic development, spanning from navigating regulatory frameworks, to designing robust clinical trials and crafting compelling target product profiles. EVolution Therapeutics will also receive £25,000 funding to support with these activities.
This partnership with SPARK The Midlands promises to equip EVolution Therapeutics with the essential support and start-up know-how necessary to navigate the complex landscape of healthcare product development. We are excited about the opportunities that lie ahead and look forward to leveraging SPARK’s expertise to accelerate our journey towards making a meaningful impact in healthcare.